EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Recurrent IgA1-λ-Type PGNMID Achieving Remission with Conventional Immunosuppressive Therapy: A Case Report

Kazuki Chida, Atsushi Oura, Tasuku Takahashi, Machi Kiyohara, Kaho Matsumoto, Tetsuya Kyo, Yusuke Ishizuka, Hitomi Kamei, Yuki Nakamura, Izaya Nakaya

Internal Medicine · 2025

DOI: 10.2169/internalmedicine.6357-25 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Internal Medicine, 2025. Verfasst von Kazuki Chida und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Japan. Hauptthemen laut MEDLINE: Immunosuppressive Agents, Immunoglobulin A, Glomerulonephritis, Membranoproliferative, Immunoglobulin lambda-Chains. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 58-year-old man was admitted to our hospital in April 2013 with elevated serum creatinine levels, proteinuria, and hematuria. A renal biopsy revealed membranoproliferative glomerulonephritis-like changes. Immunofluorescence showed IgA1 and λ light chain deposits along the capillary walls, confirming IgA-λ type proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID). Complete remission was achieved with glucocorticoid monotherapy in December 2013. After a relapse in April 2021, immunosuppressive treatment, including intravenous cyclophosphamide and subsequent mycophenolate mofetil, led to a complete remission. This case indicates that conventional immunosuppressive therapy may be effective for IgA-type PGNMID.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunosuppressive AgentsImmunoglobulin AGlomerulonephritis, MembranoproliferativeImmunoglobulin lambda-ChainsHumansMaleMiddle AgedRemission InductionRecurrenceMycophenolic AcidCyclophosphamide

Stichwörter der Autor:innen

IgA-type PGNMIDclone-directed therapyimmunosuppressive therapymonoclonal gammopathy of renal significanceproliferative glomerulonephritis with monoclonal immunoglobulin deposits

Substanzen

Immunosuppressive AgentsImmunoglobulin AMycophenolic AcidImmunoglobulin lambda-ChainsCyclophosphamide

Autor:innen und Institutionen

  • Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Japan.

Zitieren

APA

Chida, K., Oura, A., Takahashi, T., Kiyohara, M., Matsumoto, K., Kyo, T., Ishizuka, Y., Kamei, H., Nakamura, Y., & Nakaya, I. (2025). Recurrent IgA1-λ-Type PGNMID Achieving Remission with Conventional Immunosuppressive Therapy: A Case Report. Internal Medicine. https://doi.org/10.2169/internalmedicine.6357-25

Vancouver

Chida K, Oura A, Takahashi T, Kiyohara M, Matsumoto K, Kyo T, et al. Recurrent IgA1-λ-Type PGNMID Achieving Remission with Conventional Immunosuppressive Therapy: A Case Report. Internal Medicine. 2025. doi:10.2169/internalmedicine.6357-25

BibTeX
@article{Chida2025,
  author = {Chida, Kazuki and Oura, Atsushi and Takahashi, Tasuku and Kiyohara, Machi and Matsumoto, Kaho and Kyo, Tetsuya and Ishizuka, Yusuke and Kamei, Hitomi and Nakamura, Yuki and Nakaya, Izaya},
  title = {Recurrent IgA1-λ-Type PGNMID Achieving Remission with Conventional Immunosuppressive Therapy: A Case Report},
  journal = {Internal Medicine},
  year = {2025},
  doi = {10.2169/internalmedicine.6357-25}
}
Kostenlos starten →